9-649750-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_015158.5(KANK1):​c.-83-27140C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.634 in 151,982 control chromosomes in the GnomAD database, including 33,422 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.63 ( 33422 hom., cov: 31)

Consequence

KANK1
NM_015158.5 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0820

Publications

9 publications found
Variant links:
Genes affected
KANK1 (HGNC:19309): (KN motif and ankyrin repeat domains 1) The protein encoded by this gene belongs to the Kank family of proteins, which contain multiple ankyrin repeat domains. This family member functions in cytoskeleton formation by regulating actin polymerization. This gene is a candidate tumor suppressor for renal cell carcinoma. Mutations in this gene cause cerebral palsy spastic quadriplegic type 2, a central nervous system development disorder. A t(5;9) translocation results in fusion of the platelet-derived growth factor receptor beta gene (PDGFRB) on chromosome 5 with this gene in a myeloproliferative neoplasm featuring severe thrombocythemia. Alternative splicing of this gene results in multiple transcript variants. A related pseudogene has been identified on chromosome 20. [provided by RefSeq, Dec 2014]
KANK1 Gene-Disease associations (from GenCC):
  • spastic quadriplegic cerebral palsy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • cerebral palsy, spastic quadriplegic, 2
    Inheritance: AD, Unknown Classification: LIMITED Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_015158.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.891 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015158.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KANK1
NM_015158.5
MANE Select
c.-83-27140C>T
intron
N/ANP_055973.2Q14678-1
KANK1
NM_001256876.3
c.-83-27140C>T
intron
N/ANP_001243805.1Q14678-1
KANK1
NM_001256877.3
c.-83-27140C>T
intron
N/ANP_001243806.1Q14678-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KANK1
ENST00000382297.7
TSL:1 MANE Select
c.-83-27140C>T
intron
N/AENSP00000371734.2Q14678-1
KANK1
ENST00000382303.5
TSL:1
c.-83-27140C>T
intron
N/AENSP00000371740.1Q14678-1
KANK1
ENST00000619269.5
TSL:5
c.-83-27140C>T
intron
N/AENSP00000477725.2A0A8J9BYE6

Frequencies

GnomAD3 genomes
AF:
0.634
AC:
96302
AN:
151864
Hom.:
33365
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.899
Gnomad AMI
AF:
0.617
Gnomad AMR
AF:
0.690
Gnomad ASJ
AF:
0.526
Gnomad EAS
AF:
0.877
Gnomad SAS
AF:
0.433
Gnomad FIN
AF:
0.531
Gnomad MID
AF:
0.541
Gnomad NFE
AF:
0.480
Gnomad OTH
AF:
0.598
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.634
AC:
96423
AN:
151982
Hom.:
33422
Cov.:
31
AF XY:
0.635
AC XY:
47178
AN XY:
74272
show subpopulations
African (AFR)
AF:
0.899
AC:
37271
AN:
41474
American (AMR)
AF:
0.690
AC:
10528
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.526
AC:
1822
AN:
3466
East Asian (EAS)
AF:
0.877
AC:
4541
AN:
5176
South Asian (SAS)
AF:
0.432
AC:
2081
AN:
4816
European-Finnish (FIN)
AF:
0.531
AC:
5602
AN:
10540
Middle Eastern (MID)
AF:
0.561
AC:
165
AN:
294
European-Non Finnish (NFE)
AF:
0.479
AC:
32578
AN:
67946
Other (OTH)
AF:
0.605
AC:
1272
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1555
3109
4664
6218
7773
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
748
1496
2244
2992
3740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.536
Hom.:
43340
Bravo
AF:
0.663
Asia WGS
AF:
0.701
AC:
2435
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
6.8
DANN
Benign
0.56
PhyloP100
0.082
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2031175;
hg19: chr9-649750;
COSMIC: COSV63215017;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.